Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Transcat (TRNS) Capital Expenditures (2019 - 2025)

Transcat's Capital Expenditures history spans 12 years, with the latest figure at $2.7 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 6.62% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $14.4 million, down 1.9%, while the annual FY2025 figure was $13.2 million, 0.62% down from the prior year.
  • Capital Expenditures for Q4 2025 was $2.7 million at Transcat, down from $4.4 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $4.6 million in Q2 2025 and bottomed at $1.2 million in Q2 2021.
  • The 5-year median for Capital Expenditures is $2.7 million (2025), against an average of $3.0 million.
  • The largest annual shift saw Capital Expenditures skyrocketed 99.42% in 2022 before it plummeted 47.22% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $2.1 million in 2021, then increased by 13.68% to $2.4 million in 2022, then surged by 53.77% to $3.7 million in 2023, then dropped by 21.5% to $2.9 million in 2024, then decreased by 6.62% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for TRNS's Capital Expenditures are $2.7 million (Q4 2025), $4.4 million (Q3 2025), and $4.6 million (Q2 2025).